"Dire wolves" created by Colossal Biosciences were pegged as "the first animals in history to be brought back from extinction ...

The sale brings attention back to privacy concerns as Regeneron now controls genetic data from millions of 23andMe customers.

AI evolves beyond mere algorithms to open up new frontiers in generative AI and agentic AI, and the art of the possible is ...

Melissa Beson, 37, was last seen on the Lac du Flambeau Reservation on March 17. She is the fifth person to go missing from ...

Carlo Ratti's exhibition at the Venice Architecture Biennale 2025 is ambitious, very rich in ideas, projects, researches and ...

Many investors love the "big mo." That's short for "big momentum." Stocks that are on a roll often keep the good times going.

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

A new University of Florida study published in HortScience shows how drones can do more than just take aerial pictures and ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...